Abstract
Introduction 30 31
Gas vesicle nanoparticles (GVs) are gas-containing spindle-(or bicone-) shaped protein 32 nanostructures with dimensions ranging from tens to hundreds of nm that are expressed in the 33 cyanobacteria, algae and gram-positive bacteria. Since only gas molecules are permeable to the 34 GV protein shell, GV-containing organisms acquire buoyancy by selective permeation of 35 various ambient gases in the GV interior, which facilitates optimal supply of light and nutrition 36 1-3 . While GVs have been studied in the field of microbiology for several decades, they have 37 gained significant attention in recent years for their potential use for antigenic peptide display 38 in vaccination 4 , and as genetically-encodable contrast agents for ultrasonography 5 6 7 and 39
HyperCEST MRI 8, 9 . Among these applications, HyperCEST MRI, which utilizes laser-40 polarized xenon-129 (HPXe) and chemical exchange saturation transfer (CEST) 10 to yield 41 unprecedented enhanced MRI detection sensitivity, is of particular interest as GVs hold the 42 potential to enable functional molecular imaging that is unfeasible in conventional thermally-43 polarized proton MRI. (In principle, GV concentrations of as low as pM -nM can be detected.) 44
In this context, GVs can be thought of as an MRI analog of the green fluorescent protein (GFP) 45 optical imaging reporter; with a genetically-encodable nature and multiplexing capability 46 facilitated by ready modulation of their size and shape, similar to the multi-color variant of 47 GFPs 8 . However, despite their attractive features for imaging cellular / molecular processes, 48 the practical in-vivo use of GVs as genetically-encoded contrast agents is at present hampered 49 by a lack of robust techniques to introduce GVs into mammalian cells, which has been 50 considered challenging due to the complexity of GV gene clusters 11 .
51
GVs are composed of multiple proteins, and the number of genes responsible for GV 52 expression is usually 8 -14 (typically denoted GvpA, B, C etc.). Among these genes, the 53 principal component proteins are the hydrophobic major protein GvpA and hydrophilic minor 54 protein GvpC; the roles of other accessary GV genes in constituting GV wall structure remains 55 a subject of controversy 3 . In order to optimize GV delivery in-vivo, understanding of the 56 minimal number and type of GV gene components required to reconstitute the GV 57 nanostructure in mammalian cells is crucial. In this study, we focus on the unique gene clusters 58 of GVs derived from Planktothrix rubescens/agardhii (praGV). The praGV gene clusters have 59 been studied extensively by Walsby and coworkers [12] [13] [14] , who showed that parts of praGV gene 60 clusters are composed of gvpA and three variants of gvpC named gvpC16, gvpC20 and gvpC28, 61 though it is known that existence of other accessary GV genes have also been demonstrated 3 .
62
Properties of praGVs such as size, shape and stiffness (pressure threshold for collapse) are 63 known to be modulated depending on the combination of gvpC variants included in their 64 constituent gene clusters 13 were cloned to the 3' ends of GV genes (according to schemes in Figure 1a ), for quantitative 82 evaluation of GV gene expression by flow cytometry. T2A sequences were self-excised just 83 after translation to avoid inhibiting GV structure formation, for example by steric hindrance of 84 linked fluorescent proteins. We offer expression vectors of these humanized praGV genes at 85 the National Bio-resource Center (https://dnaconda.riken.jp/search/depositor/dep103337.html).
86
Combinations of praGV gene constructs were co-transfected into KPL-4 human breast 87 cancer cells 22 . Combinations were chosen in reference to the natural Planktothrix 88 rubescens/agardhii GV gene clusters 13 . In this study, we investigated 3 specific combinations: 89 gvpA + gvpC20 (GV_AC20), gvpA + gvpC28 (GV_AC28) and gvpA + gvpC16 + gvpC20 90 (GV_AC16C20). Transfected cells expressing the GV gene sets at high levels were selected 91 using puromycin selection and fluorescence-activated cell sorting (FACS). Monoclonal single 92 colonies were picked and expanded for GV_AC20, GV_AC28 and GV_AC16C20 cells.
93
Obtained monoclonal cell pellets are shown in Figure 1b . Expression levels of the fluorescent 94 proteins of the monoclonal cultures were measured by flow cytometry (Supplementary Figure  95 1). The expected cellular burden to express these GV genes in mammalian cells was evaluated 96 by a cell proliferation assay using a WST-8 reagent (Materials and Methods). GV_AC28 cells 97
showed a significant decrease of cell proliferation after 72 hours of induced GV gene 98 expression with doxycycline (Dox+) (p = 0.024, t-test) compared with that of non-induced 99 control cells (Dox−) (Figure 1c ). Other GV cells did not show a significant decrease of cell 100 proliferation (p = 0.86, 0.18 and 0.34, t-test for control, GV_AC20 and GV_AC16C20 cells, 101 respectively).
102
To confirm expression of foreign protein nanoparticles in the cells, we developed a 103 method of purifying buoyant protein nanoparticles from mammalian cells (Figure 2a ). The 104 protocol was modified from that previously described 23 to exploit the much lower density of 105
GVs compared to water. The purified putative nanoparticle suspensions were observed by TEM.
106
Characteristic bicone structures were observed when using a standard negative staining 107 protocol (Materials and Methods) in a purified suspension of the GV_AC28 cells ( Figure 2b ).
108
In other cell clusters, distinct structures were not observed. Thus, we tested another protocol, 109 usually adopted for observation of intracellular structures in cells, which we proposed would 110 help avoid collapse of the nanoparticles during TEM observation. Putative nanoparticle 111 suspensions were first embedded in ~ 1 mm 3 2% agarose gels and fixed with glutaraldehyde 112 (GA) (Materials and Methods). Using this protocol, distinct bicone structures were also 113 observed in suspensions purified from GV_AC20 and GV_AC16C20 cells (Figure 2b ). It is 114 noteworthy that these observed nanostructure were not cellular organelles or any membranous 115 structures, because they were collapsed by the act of osmotic pressure and detergent used in 116 the purification method. We additionally note that the TEM images could not be any salt 117 crystals because applied staining method specifically contrasted the proteins. We also obtained 118
Dynamic Light Scattering data on the purified nanoparticle suspensions to gain insights into 119 the size distribution of the protein nanoparticles (Supplementary Figure S2) . The obtained TEM 120 images and DLS data clearly indicated the expression of characteristic bicone nanostructures 121 in mammalian cells for each of our GV gene constructs, and genetic control of their size and 122 shape was observed, as hypothesized (Supplementary Text). In addition, the cell proliferation 123 assay indicated that cellular burden of these nanoparticle expression in mammalian cells may 124 depend on the expressed nanoparticle size (Figure 1c ). 125
Moreover, we were able to clearly observe the nanostructures in GV_AC28 cells as a 126 negative contrast by fluorescent confocal microscopy due to their large size (above the spatial 127 resolution of confocal microscopy) (Figure 2c The HyperCEST Z-spectrum of GV_AC28 cell samples consistently showed a maximal 142 signal decrease at around 20 ppm saturation offset chemical shift, and occasionally minor 143 saturation peaks at around 70 ppm, in addition to the bulk dissolved phase HPXe saturation 144 peak at 194 ppm, while the control KPL-4 cells showed only the 194 ppm saturation peak of 145 bulk dissolved xenon with a broad and weak background around 0 ppm ( Figure 3a ). We believe 146 the two unique peaks of GVLP-bound xenon may be explained by the inhomogeneity of GVLP 147 size in GV_AC28 cells as indicated in TEM images ( Figure 2b ) and DLS data (Supplementary 148 Figure 2 ). The 20 ppm peak may be attributed to the xenon bound to large vesicles and the 149 minor peak (~70 ppm) presumably relates to the xenon bound to smaller vesicles 24 .
150
Furthermore, we observed a slight, but repeatable saturation peak of GV_AC16C20 cells at 151 around 60 ppm in its Z-spectrum despite a lower number of GV cells (2.0 x 10 7 cells / ml vs. 152 8.0 x 10 7 cells / ml for GV_AC28 cells). In this case, the background signal in the Z-spectrum 153 was reduced, similar to that previously reported for the β-lactamase HyperCEST reporter gene 154
11 . Therefore, we concluded that the peak at 60 ppm was indeed derived from the saturated GV-155 bound xenon transfer rather than an experimental artifact ( Figure 3a ). On the other hand, the 156 Z-spectrum of GV_AC20 cells (Supplementary Figure 3) did not show any practical saturation 157 peaks for HyperCEST contrast at 2 s saturation time.
158
Subsequently, bulk dissolved xenon NMR signal intensity was measured after applying 159 saturation pre-pulses at the on-resonance and off-resonance chemical shifts (on-resonance 160 signal intensity Son and off-resonance signal intensity Soff, respectively) as a function of 161 saturation time and the %CEST contrast was calculated as defined in the equation for 162 GV_AC28 and GV_AC16C20 cells ( Figure 3b ): % =
× 100. 163
In GV_AC28 cells, chemical shifts of on-resonance and off-resonance saturation pre-164 pulses were set to 20 ppm and -20 ppm, respectively, and for GV_AC16C20, 60 ppm and -60 165 ppm were used. GV_AC28 cells showed 5.5 ± 1.3 and 6.5 ± 0.9 % CEST contrast at 1.5 s and 166 2 s saturation time, respectively. At 3 s saturation time, CEST contrast maximally reached 8.0 167 ± 0.7 %. For GV_AC16C20 cells, 2.6 ± 1.1 and 3.1 ± 1.5 % CEST contrast was observed at 168 1.5 s and 2 s saturation time, with a maximal 5.8 ± 0.7 % contrast at 2.5 s saturation time.
169
Considering the longitudinal relaxation time (T1) of gaseous xenon in vivo (~ 30 s, note that 170 the T1 of dissolved xenon is lower), the saturation time for in-vivo HyperCEST MRI should 171 ideally be less than 2 s 25, 26 . It is noteworthy that a low saturation time is also desirable for 172 decreased specific absorption rate, which is an important consideration regarding the 173 application of GVs in human patients. Taking these concerns into account, a HyperCEST MR 174 image of GV_AC28 cells was successfully acquired by applying a 2 s saturation scheme at 20 175 ppm (Figure 3c ). 176 177
Conclusions

178
In this study, we showed that expression of reduced GV gene sets derived from 179 planktothrix rubescenes/agardhii in mammalian cells resulted in the formation of GVLPs in 180 the cell and they could be functionalized as a genetically- 
MATERIALS AND METHODS
365
Synthesis of humanized GV genes 366 GV genes were searched in Genbank over as many strains as possible derived from planktothrix 367 rubescens/agardhii to synthesize humanized genes for mammalian expression of GV proteins. 368
The gene gvpA was chosen from the strain pla-9303, gvpC16 from pla-9401, gvpC20 from pla-369 9401 of Planktothrix rubescens and gvpC28 from Planktothrix agardhii CYA29. Coding 370 sequences of these genes with codons optimized for expression in mammalian hosts were 371 synthesized (outsourced to Genscript). 372 373
Molecular cloning 374
Primers used for gene cloning were purchased from Hokkaido System Science. Coding 375 sequences of GV genes were PCR-amplified with 5' primers encoding a NheI site and 3' 376 primers encoding an EcoRI site without termination codons using KOD-plus-Neo (TOYOBO). 377 T2A -fluorescent protein (mKate2, mKO2 and EGFP) fusion genes were also PCR amplified 378 with 5' primers encoding an EcoRI site and 3' primers encoding a NotI site. A Tol2 cloning 379 vector (donated by Dr. Akira Takai of RIKEN and described in detail previously [16] [17] [18] ) was also 380 digested in the same way. The PCR products and restriction enzyme digestions were purified 381 by agarose gel electrophoresis followed by processing with the Wizard SV Gel and PCR clean 382 up system (Promega). Restriction enzymes were purchased from Fermentas. The digested PCR 383 products of GV genes and T2A-fluorescent protein fusion genes were ligated to the vectors 384 using Ligation high Ver.2 ligase (TOYOBO) following the recommended protocol of the 385 manufacturer. Plasmids were prepared from the bacterial liquid culture by using the Pure Yield 386
Plasmid Miniprep System (Promega) and PureLink HiPure Plasmid Midiprep Kit (Invitrogen).
387
The DNA sequences were read by dye terminator cycle sequencing using the BigDye 388
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). 389 390
Transfection and cell culture 391
Plasmid DNAs containing Tol2 vectors comprising GV genes and fluorescent protein genes 392 described above and transposase mRNA were introduced to KPL-4 cells by lipofection using 393
FuGene HD (Promega) in OptiMEM (Gibco), according to manufacturer protocols.
394
Transfected cells were maintained in a low-glucose DMEM (FUJIFILM Wako Pure Chemical 395 Corporation) with 10% FBS (Gibco) and 1% penicillin-streptomysine (Gibco). 396 397 KPL-4 monoclonal cell lines expressing GV gene sets 398 KPL-4 cells were transfected with the GV gene constructs and 1 µg/ml puromycin (Invitrogen) 399 was added to cell cultures to select only the transfected cells. The cells were sorted several 400 times to collect polyclonal cells expressing GV gene sets at high levels (＞ x 10 2 fluorescence 401 intensity compared to control cells) by detecting fluorescence of mKate2, mKO2 and EGFP in 402 correlation with the expression levels of GV genes using a BD FACS Aria Ⅲ cell sorter (BD centrifuged, collected and re-suspended in PBS. The samples were transferred to a new 15 ml 428 sample tube, centrifuged again and cell pellets were collected. The cell pellets were suspended 429 in 5 ml pure water at 4 ℃ with 0.4 % TritonX-100 (Sigma-Aldrich), 2 μl DNAaseⅠ(Sigma 430 Aldrich) and a protease inhibitor cocktail (Roche). The samples were incubated at 4 ℃ with 431 gentle mixing for two hours. The same amount of 1.3 M sucrose solution (5 ml) was added to 432 the sample (thus the final sucrose concentration was 0.65 M), which was then incubated for a 433 further two hours with gentle mixing at 4 ℃. 0.5 ml PBS was then carefully placed on the 434 surface of the sample. The samples were then centrifuged for over 4 hours at 100 x g at 4 ℃ 435 with a swing bucket rotary and appropriate balance to keep the rotating samples perpendicular 436 to the gravity axis. After the centrifugation, ~ 200 µl samples were collected from the sample 437 surface and the GVLP suspension was used for subsequent analysis. 438 439
Transmission Electron Microscopy (TEM) 440
Purified GVLP samples were prepared for TEM analysis in two ways: (1) Purified GVLP from 441 GV_AC28 cells was fixed with the same amount of 2.5 % glutaraldehyde (GA) solution 442 (FUJIFILM Wako Pure Chemical Corporation) and prepared with a standard negative staining 443 protocol as follows. Purified suspension of 3 µl was placed onto the 200 mesh copper grid and 444 incubated for 60 seconds. The extra solution was absorbed with filter paper and a water droplet 445 of 3 µl was placed on the grid. The droplet was absorbed again immediately with filter paper, 446 a 2 % uranium acetate droplet of 3 µl was placed on the grid and absorbed 3 times. The dried 447 sample was then used for TEM JEM1011 (JEOL) at an acceleration voltage of 100 kV. (2) 448 GV_AC20 cells and purified GVLPs from GV_AC20 cells and GV_AC16C20 cells were first 449 embedded in 2 % agarose gels (~ 1 mm 3 ) prior to fixation. After the fixation with half 450 Karnovsky mixture (2.5 % GA and 2 % paraformaldehyde), the samples were dehydrated by 451 soaking them with 30 %, 50 %, 70 %, 80 % and 90 % sequences for 10 minutes each. After 452 that, samples were soaked three times with 100 % ethanol. Samples were then soaked with 453 100 % propylene oxide (PO) for 10 minutes and in 1:1 and 1:2 mixture of PO solvent and 454
Quetol-812 (Nisshin EM) epoxy resin (EPON) for 6 hours and 2 hours, respectively. 455
Furthermore, the samples were soaked in a mixture of EPON and epoxy curing agent DMP-30 456 for 6 hours. Finally, the samples were embedded in the same EPON and DMP-30 mixture 457 formed with a plastic or silicon mold and cured in the oven at 45 ℃ for 24 hours and at 60 ℃ 458 for 72 hours, respectively. The obtained resin block was trimmed with a glass knife and ultra-459 thin sections (~ 70 nm) were prepared using a Leica EM UC7 ultramicrotome (Leica) and ultra 460 diamond knife 35°(Diatome 
Selection of GV genes 541
We chose the gvpC28 gene from planktothrix agardhii instead of planktothrix rubescens in this 542 study because the full sequence of the gvpC28 gene was not available on the Genbank database.
543
In addition, because previous studies indicated that a heterologous combination of GV genes 544 could be utilized to induce GVs with altered size and shape into bacterial species 1 , we assumed 545 that the heterologous combination of GV genes derived from planktothrix rubescens and 546 planktothrix agardhii could be used to produce GVLPs for these closely related strains. 547
Notes on TEM observation of GV structures 548
In an initial effort to confirm GVLP expression in the cells, we observed ultra-thin slices of 549 embedded GV_AC20 cell samples by TEM and found the putative GVLPs (indicated white 550 arrow in Supplementary Figure 4) , exhibiting the characteristic bicone structure, although the 551 complexity of other intracellular components made it difficult to undeniably confirm GV 552 expression. 553
It is noteworthy that fixation of the GVLP purified from GV_AC28 cells with 2.5 % 554 glutaralaldehyde (GA) prior to drying and staining was found to be essential for observation of 555 distinct GV structures; without GA fixation, we could not observe distinct GV structures in our 556 experiments (Supplementary Figure 5) . 557
Purified GVLP structure and size distribution 558
The TEM image of GVLPs purified from GV_AC20 cells in Figure 2b shows that the width 559 and length of GVLPs was heterogeneous and ranged from ~ 200 nm to 300 nm. GVLP shape 560 appeared to be biconical or cylindrical without conical ends, comprising a linear outline. The 561 observed cylinders without conical ends may indicate deficient structure formation (e.g. lack 562 of closed protein shell structure); this would reasonably explain the discrepancy between 563 observed TEM sizes ( Figure 2b ) and lower size distribution peak of about 90 nm in DLS data 564 (Supplementary Figure 2) . In contrast, TEM images of GVLPs purified from GV_AC28 cells 565 indicated a more rounded outline compared to other GV cells. The GV size ranged from 100 566 nm to 700 nm, and included the largest GVs among all that were generated. The two peaks of 567
GVLPs purified from GV_AC28 cells in Dynamic Light Scattering (DLS) data 568
(Supplementary Figure 2) may corresponded to the relatively broad particle size distribution of 569 GVLP in GV_AC28 cells and/or aggregation of the particles. The TEM data showed that the 570 length of GVLPs purified from GV_AC16C20 cells was around 100 nm or less, with a width 571 of 50 -60 nm. DLS data of GVLPs purified from GV_AC16C20 cells indicated a relatively 572 homogeneous size distribution with a peak at ~ 80 nm, which is in accordance with the TEM 573 data. 574 
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